chr12-59775099-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_001270623.2(SLC16A7):​c.804G>C​(p.Leu268Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)

Consequence

SLC16A7
NM_001270623.2 missense

Scores

7
10
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.60
Variant links:
Genes affected
SLC16A7 (HGNC:10928): (solute carrier family 16 member 7) This gene is a member of the monocarboxylate transporter family. Members in this family transport metabolites, such as lactate, pyruvate, and ketone bodies. The protein encoded by this gene catalyzes the proton-linked transport of monocarboxylates and has the highest affinity for pyruvate. This protein has been reported to be more highly expressed in prostate and colorectal cancer specimens when compared to control specimens. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SLC16A7NM_001270623.2 linkuse as main transcriptc.804G>C p.Leu268Phe missense_variant 5/6 ENST00000547379.6 NP_001257552.1 O60669A0A024RBB2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SLC16A7ENST00000547379.6 linkuse as main transcriptc.804G>C p.Leu268Phe missense_variant 5/61 NM_001270623.2 ENSP00000448071.1 O60669

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 10, 2024The c.804G>C (p.L268F) alteration is located in exon 4 (coding exon 3) of the SLC16A7 gene. This alteration results from a G to C substitution at nucleotide position 804, causing the leucine (L) at amino acid position 268 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.89
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Pathogenic
0.16
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.45
T;T;T;T;T
Eigen
Pathogenic
0.80
Eigen_PC
Pathogenic
0.74
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.87
.;.;.;D;D
M_CAP
Benign
0.040
D
MetaRNN
Uncertain
0.71
D;D;D;D;D
MetaSVM
Uncertain
0.099
D
MutationAssessor
Pathogenic
3.6
H;H;H;.;H
PrimateAI
Uncertain
0.65
T
PROVEAN
Uncertain
-3.6
D;D;D;D;D
REVEL
Uncertain
0.42
Sift
Uncertain
0.0020
D;D;D;D;D
Sift4G
Uncertain
0.0030
D;D;D;D;D
Polyphen
1.0
D;D;D;.;D
Vest4
0.78
MutPred
0.57
Gain of catalytic residue at A269 (P = 0);Gain of catalytic residue at A269 (P = 0);Gain of catalytic residue at A269 (P = 0);Gain of catalytic residue at A269 (P = 0);Gain of catalytic residue at A269 (P = 0);
MVP
0.78
MPC
0.40
ClinPred
0.99
D
GERP RS
5.8
Varity_R
0.90
gMVP
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr12-60168880; API